Hemangioendothelioma Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Percutaneous Administration of Sirolimus in the Treatment of Superficial Complicated Vascular Anomalies
Conditions: Kaposiform Hemangioendothelioma; Tufted Angioma; Superficial Vascular Anomalies; Superficial Lymphatic Malformations Interventions: Drug: Percutaneous sirolimus; Drug: Oral sirolimus Sponsor: Children's Hospital of Fudan University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 10, 2021 Category: Research Source Type: clinical trials
